13F-HR filed by Foresite Capital Management VI LLC
Foresite Capital Management VI LLC filed this 13F-HR for the quarter ended 2026-03-31, filed 2026-05-15, with 17 holding rows worth $460,271,345.
- Accession
- 0001104659-26-062467
- Filer
- CIK 2013341
- Filed
- 2026-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2026
A holdings report, 17 entries on the cover page, a total value of $460,271,345 stated on the cover page (in dollars after the unit check, H1), rows summing to $460,271,345 with VALUE read as dollars as filed, 13F file number 028-25267. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| CG ONCOLOGY INC | 156944100 | COMMON STOCK | 2,221,474 | $150,349,360 | dollars as filed | |
| ALUMIS INC | 022307102 | COM | 4,247,670 | $93,576,170 | dollars as filed | |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 1,364,019 | $54,178,835 | dollars as filed | |
| CORVUS PHARMACEUTICALS INC | 221015100 | COM | 1,831,233 | $26,790,939 | dollars as filed | |
| DENALI THERAPEUTICS INC COM | 24823R105 | Stock | 1,209,971 | $23,231,443 | dollars as filed | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 525,000 | $17,760,750 | dollars as filed | |
| VERASTEM INC | 92337C203 | COMMON STOCK | 3,146,631 | $16,677,144 | dollars as filed | |
| KYMERA THERAPEUTICS INC | 501575104 | COM | 146,332 | $12,187,992 | dollars as filed | |
| MINERVA NEUROSCIENCES INC | 603380205 | COM NEW | 1,986,600 | $11,969,265 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 315,913 | $10,020,760 | dollars as filed | |
| ATAIBECKLEY INC | 04650F101 | COM SHS | 2,750,000 | $9,735,000 | dollars as filed | |
| HINGE HEALTH INC A | 433313103 | COMMON STOCK | 220,400 | $8,498,624 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 212,010 | $7,700,203 | dollars as filed | |
| ONKURE THERAPEUTICS INC | 68277Q105 | COM CL A | 1,445,783 | $5,985,542 | dollars as filed | |
| JADE BIOSCIENCES INC | 008064206 | COM NEW | 320,000 | $4,496,000 | dollars as filed | |
| GH RESEARCH PLC ORDINARY SHARES | G3855L106 | Stock | 315,492 | $4,435,818 | dollars as filed | |
| ZURA BIO LTD | G9TY5A101 | COMMON STOCK | 450,000 | $2,677,500 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-26-062467 | this filing | 2026-05-15 | acceptance time not in the bulk data set |